About Us

Metanotitia Inc. is a professional metabolomics company dedicated to transform treatment decisions and outcomes by delivering clinically actionable diagnostics, specializing in offering one-stop solutions by leveraging the power of metabolomics. The founding team transferred the top-tier technology and more than 20 years of scientific research experience in metabolomics from Germany to Shenzhen, China, and is committed to upgrading the ProfMet metabolomics R&D platform. We are dedicated to combine high-quality human metabolome data with AI advances to speed up the innovation of metabolomic IVD and integrate personalized care into the standard-of-care.

Core Leadership Team & Scientific Advisors

Metanotitia’s core leadership team consists of research scientists and doctors each with decades of diagnostic development, engineering, and biochemistry experience. Additionally, the team consists of well experienced business professionals and leaders.The team’s goal is to drive discovery, transform scientific findings, and reduce regulatory and technical risks.

Chairman
Junyuan Hu, PhD

Dr. Hu holds a PhD in Biochemistry and Molecular Biology at the University of Gothenburg and Chalmers University of Technology, Sweden, and was a postdoctoral fellow at the Department of Biochemistry and Molecular Biology at the University of British Columbia, Canada.He was one of the first batch of experts of the “Thousand Talents Program” of China, but also the Chairman of Shenzhen Beike Biotechnology Co., Ltd, and the director of Shenzhen Beike Cell Engineering Institute. On June 2011, he initiated the establishment of Chinese national stem cell and regenerative medicine industry technology innovation strategic alliance and was elected as the first vice Chairman of the union. In 2012, he was invited to initiate the preparation of the Boao Forum for Asia World Life Science Forum.He is also the Vice Chairman of China National Stem Cell and Regenerative Medicine Industry Technology Strategic Innovation Alliance, the executive director of Regenerative Medicine Technology Committee of China Pharmaceutical Biotechnology Association, the vice president of Shenzhen International Economic Promotion Association, the visiting professor of Department of Surgery of Chinese University of Hong Kong, the visiting professor of Shanghai Cardiovascular Institute of Fudan University.

Director, CEO
Yan Li, PhD

Dr. Li earned her PhD in Biochemistry from Max Planck Institute for Molecular Plant Physiology, Germany. She has been engaged in mass spectrometry-based metabolomics research and translational applications. Her focus in healthcare big data, keen marketing insights and pioneered R&D concepts, facilitated the establishment of Metanotitia Inc in 2018. She has localized and upgraded the German-oriented advanced mass spectrometry-based  metabolomics technology. Dr. Li was the driving force behind Metanotitia's team formation, laboratory construction, technical development, clinical trials, product commercialization, and overall operation and management.

Director
Gang Bai, PhD

Dr. Bai is one of the directors in Metanotitia. As a renowned expert in corporate strategy, he has a PhD in management from Renmin University of China, and is a professor of EMBA at Shenzhen Institute of Renmin University. He has worked as a strategy expert consultant in several famous enterprises in China, specializing in organizational capacity building. His main research areas include strategy and organizational change, business unit transformation, process reengineering and supply chain management, marketing strategy, planning and budget management, and human resource management.

Interdisciplinary Team of Experts

Metanotitia Inc. has built a rockstar team of talented and passionate professionals and scientists from home and abroad. Those young, bright, and energetic members ensures truly game-changing metabolomics R&D with deep scientific and technical foundation.Metanotitia encourages cross-pollination of various disciplines to promote innovations. We provide smooth promotion channels and dual training of technology and management for people with composite talents.

Interdisciplinary Team of Experts
View all
Guangdong Pharmaceutical University
Beijing Technology and Business University
University of California, Davis
Sun Yat-sen University
South-Central Minzu University
Guangdong University of Technology
Xiamen University
University of Potsdam
Monash University
Hunan Normal University
University of Göttingen
Johns Hopkins University
China Pharmaceutical University
Wuhan University
Wuhan University of Technology
Huazhong Agricultural University
Seoul National University
University of South Florida
Sorbonne University
South China Normal University
University of Wisconsin-Madison
1 / 6
Interdisciplinary Team of Experts
Guangdong Pharmaceutical University
Beijing Technology and Business University
University of California, Davis
Sun Yat-sen University
South-Central Minzu University
Guangdong University of Technology
Xiamen University
University of Potsdam
Monash University
Hunan Normal University
University of Göttingen
Johns Hopkins University
China Pharmaceutical University
Wuhan University
Wuhan University of Technology
Huazhong Agricultural University
Seoul National University
University of South Florida
Sorbonne University
South China Normal University
University of Wisconsin-Madison
Corporate Culture

Holding up virtues of "Respectful, Cooperative, Passionate, and Connective", Metanotitia continues to promote the technology innovation and metabolomics practices to change the world with  precision medicine. Together, we seize the future!



Mission

Dedicate to improve the quality of life

Strive to extend the length of life

Vision

Pursuit the best metabolomics

Empowering people to live their best lives

Values

Integrity is in our blood

Open, connected, people-oriented

Cooperation and Partnerships

Metanotitia is committed to providing one-stop metabolomics solutions leveraging the power of metabolomics.

With the first-class ProfMet platform, rich databases, and advanced algorithms, Metanotitia has successfully served partners in various fields where we provide support for the molecular profiling assays and analysis of specific disease types relating to Metanotitia’s area of focus.

We sincerely welcome interested partners in our future projects.


Our customers
  • Dairy enterprise
  • Biotech companies
  • Government
  • Pharmaceuticals
  • Colleges and universities
  • Hospitals
  • Research institutes
Product application
  • Basic Medicine
  • Clinical medicine
  • Chinese medicine
  • Environ Science
  • Animal husbandry
  • Aquaculture
  • Light industry
  • Farming and forestry
Project Cooperation
Perfect Details Define Professionalism

We have an advanced metabolomics R&D platform and an interdisciplinary professional team. We look forward to partnerships with biopharma, hospitals, universities, research institutes, and government enterprises in the precision medicine industry.

1. Project Establishment

Our experienced professionals will provide consulting and help with project setup.

2. Project Design

Discuss with our scientific experts about your research interests, to ensure the clinical and analytical needs are met, while achieving the expected project objectives.

3. Agreement

A strategic cooperation relationship will be set up between both parties ensuring resource sharing and synergistic development. A written agreement will be signed on the benefits, IP rights, decision-making mechanism, and maintenance costs.

4. Sample Collection

We will provide SOPs for sample collection, storage and transportation to help our partners to obtain qualified samples. The full process QC is ensured by our experienced operating team and synchronized information-based sample management system.

5. Sample Transportation

Samples are required to be transferred on dry ice while the temperatures are tracked throughout the transportation.

6. Sample Testing

We will design appropriate analytical methods according to the project objectives. With the Metabonum, our professional quality management system, high quality and  reproducible metabolomics data is guaranteed.

7. Data Analysis

Even facing large sample sizes, our experts still can provide the most accurate annotation and the most comprehensive analytics with the proprietary database UlibMS and processing tool Spectronaut.

8. Commercialize Research Findings

Research findings or technology created during the project can be further developed into marketable products for the benefit of the public.

Parternships and Collaborations

Are you looking to establish strategic collaboration or partnership opportunity in cancer research with an innovative and progressive research company?  We are interested in collaborations with leading researchers, institutions, and facilities with proven track records. Contact us or leave your message below.

Metanotitia Inc.
  • Service hotline

    0755-26921231
  • E-mail

    Info@metanotitia.com
  • Address

    HQ: Floor 3-4, Building C4, Building 6, Science and Technology Headquarters, Shenzhen (Harbin) Industrial Park, Zhigu Street, Songbei District, Harbin
    BO: Room 1307,13F Beike Building, Nanshan District,Shenzhen
  • Contact Us
  • Please confirm the information given above is correct, so that we can reach out to you. Metanotitia is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested.
    TOP